Mesenchymal stem cells alleviate dexamethasone-induced muscle atrophy in mice and the involvement of ERK1/2 signalling pathway

BACKGROUND: High dosage of dexamethasone (Dex) is an effective treatment for multiple diseases; however, it is often associated with severe side effects including muscle atrophy, resulting in higher risk of falls and poorer life quality of patients. Cell therapy with mesenchymal stem cells (MSCs) ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Belle Yu-Hsuan, Hsiao, Allen Wei-Ting, Shiu, Hoi Ting, Wong, Nicodemus, Wang, Amanda Yu-Fan, Lee, Chien-Wei, Lee, Oscar Kuang-Sheng, Lee, Wayne Yuk-Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403871/
https://www.ncbi.nlm.nih.gov/pubmed/37542297
http://dx.doi.org/10.1186/s13287-023-03418-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403871/
https://www.ncbi.nlm.nih.gov/pubmed/37542297
http://dx.doi.org/10.1186/s13287-023-03418-0

Ejemplares similares